Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat‐to‐target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
David R. Owens; Geremia B. Bolli; Bernard Charbonnel; Thomas Haak; Wolfgang Landgraf; Francesca Porcellati; Louise Traylor; Alexandra Kautzky‐Willer
Author Information: Diabetes Research Group, Institute of Life Sciences, College of Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.